Drug Treatment Peripheral Neuropathy Navigation


Drug Treatment Peripheral Neuropathy

|

Partners
Tell A Friend about us
Drug Treatment Counseling |
Drug Rehab Portland Oregon |
Alcohol Treatment Muncie Indiana |
Alcohol Treatment Services Beatrice Ne |
Alcohol Treatment Programs Minnesota |
Drug Addiction And Christian Recovery Resources |
Drug Addictions |
Alcohol Clinic |
Residential Addiction |
Programs For Drug Addiction |
Alcohol Treatment Omaha |
Drug And Rehab Programs |
Fort Collins Drug Alcohol Treatment |
Alcohol Treatment Fargo Nd |
Alcohol Treatment Cranston Ri |

List of Drug-Alcohol-Treatment Articles

Drug Treatment Peripheral Neuropathy Best Seller



Best Drug Treatment Peripheral Neuropathy Products

Social bookmarking
You like it? Share it!
socialize it


Main Drug Treatment Peripheral Neuropathy Sponsors


Drug Treatment Peripheral Neuropathy

 

Latest Drug Treatment Peripheral Neuropathy Link Added

Top 5 Drug and Alcohol Treatment Pages

1. Drug Rehab
2. Drug Alcohol
3. Drug Treatment
4. Drug Addiction
5. Alcohol Treatment




Submit your link on Drug Treatment Peripheral Neuropathy!


Welcome to Drug and Alcohol Treatment


 

Drug Treatment Peripheral Neuropathy Article

Thumbnail example

This is a selection made from among articles on Drug Treatment Peripheral Neuropathy. For a permanent link to this article, or to bookmark it for future reading, click here.

The Psychiatric Aspect of Drug Addiction

from:


There is a reason people become addicted to drugs. The psychiatric aspect of addiction to drugs can be very powerful. Our minds are very complex and the thoughts we have can become rulers in our lives.

Because we are these complex beings with the capabilities of thinking and reasoning, we often discount the mind as just a small part of who we are. Nothing could be further from the truth. The psychiatric implications of drug use are ever prevalent and can wreak havoc in the lives of someone with an addiction to drugs.

What exactly are we talking about? The psychiatric aspects of the mind and how our mind can control our lives is something mental professionals have known about for awhile now. It’s time you learned yourself.

For example, if you are the child of an addict – whether it be a pot-head parent or an alcoholic parent, your mind begins to justify your own marijuana use or alcohol use as being alright. After all, if your parents are doing it, it can’t be all bad for you – right? Well, that’s what your mindset becomes.

Drugs also have an effect on the brain. It’s a proven, scientific fact that addiction is a brain problem and the American Psychiatric Association has proven this. When you start using drugs, your brain gets used to having that drug around. When it’s not present, your mind starts “talking” to you and you believe what it says – that you must have that drug to function.

What can you do to try and beat the psychiatric implications of drug addiction? The best answer to that question is to get some help. That means talking to a counselor or health professional about your addiction and asking ways that you can overcome your addiction.

There are many programs available to people who are dealing with drug addiction. They treat both the mind and the body, because you will be going through some withdrawal symptoms when you decide to stop doing drugs. With professional help, you will be able to successfully conquer the hold that drug addiction has on you, your life, and your mind.

You don’t necessarily have to enter a rehab facility, but when you contact a psychiatrist or psychologist seeking help for your addictions, you will find that beating that demon will become much, much easier. Rehab facilities can be expensive and so can psychiatrists, but once you realize that you will need outside help to beat your addiction, you will be better able to get on your way to a drug-free life.





Drug Treatment Peripheral Neuropathy Specific links

Drug Treatment Peripheral Neuropathy News

FDA Advisory Committee Finds Data Support Effectiveness of Tafamidis Meglumine, Pfizer’s Novel Investigational ...

Pfizer Inc. announced today that the United States Food and Drug Administration’s Peripheral and Central Nervous System Drugs Advisory Committee voted on Pfizer’s clinical data package for tafamidis meglumine.

Read more...


Diamyd Medical's Phase II study in cancer pain fully recruited

Regulatory News:

Read more...


NeuroMetrix Engages IRG for Investor Relations

NeuroMetrix, Inc. , www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported today

Read more...


Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting

WOODCLIFF LAKE, N.J., May 17, 2012 /PRNewswire/ -- Eisai announced today that 15 abstracts highlighting new study results will be presented during the 48 th Annual Meeting of the American Society of Clinical ...

Read more...


Press Release

Pfizer Inc. (NYSE:PFE) announced today that the United States Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory Committee voted on Pfizer’s clinical data package for tafamidis meglumine.

Read more...


What Is Diabetic Neuropathy?

Diabetic neuropathy is damage that affects the peripheral nerves of the body. The damage is specifically to the nerves of the ganglia, outside of the skull, the spinal cord, and some other nerves that aid the body in assisting fundamental organs, such as the heart, bladder, intestines, and stomach. Diabetic neuropathy refers only to individuals who have diabetes. Different nerves are affected in ...

Read more...


Genta Announces Results of Tesetaxel Confirmatory Trial in Patients With Advanced Gastric Cancer

-- New Data for Response, Survival, and Safety to be Presented at ASCO

Read more...


EpiCept Reports First Quarter 2012 Operating and Financial Results

Regulatory News:

Read more...


Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic ...

RARITAN, N.J., May 17, 2012 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. today announced the results of an investigational Phase 3 study suggesting NUCYNTA® ER (tapentadol) extended-release tablets were ...

Read more...


Millennium and Seattle Genetics Initiate Global Phase 3 Trial of ADCETRIS™ in Patients with CD30-Expressing Relapsed ...

Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited and Seattle Genetics, Inc. , today announced the initiation of an international pivotal phase 3 clinical trial evaluating ADCETRIS in patients with CD30-expressing cutaneous T-cell lymphoma who received at least one prior systemic therapy.

Read more...